Castle Biosciences, Inc. (CSTL)
32.63
-0.79
(-2.36%)
USD |
NASDAQ |
Sep 03, 11:36
Castle Biosciences Cash from Operations (Quarterly) : 15.20M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 15.20M |
| March 31, 2026 | -22.13M |
| December 31, 2025 | 26.93M |
| September 30, 2025 | 22.63M |
| June 30, 2025 | 20.82M |
| March 31, 2025 | -6.036M |
| December 31, 2024 | 31.05M |
| September 30, 2024 | 23.34M |
| June 30, 2024 | 24.00M |
| March 31, 2024 | -6.835M |
| December 31, 2023 | 24.08M |
| September 30, 2023 | 5.012M |
| June 30, 2023 | -3.786M |
| March 31, 2023 | -25.44M |
| December 31, 2022 | -4.632M |
| September 30, 2022 | -5.224M |
| June 30, 2022 | -9.001M |
| Date | Value |
|---|---|
| March 31, 2022 | -21.43M |
| December 31, 2021 | -2.781M |
| September 30, 2021 | -6.133M |
| June 30, 2021 | -6.438M |
| March 31, 2021 | -3.631M |
| December 31, 2020 | -0.43M |
| September 30, 2020 | -2.955M |
| June 30, 2020 | 13.50M |
| March 31, 2020 | -0.251M |
| December 31, 2019 | 4.493M |
| September 30, 2019 | 0.7515M |
| June 30, 2019 | 0.4817M |
| March 31, 2019 | 1.288M |
| December 31, 2018 | |
| September 30, 2018 | -1.879M |
| June 30, 2018 | -4.697M |
| March 31, 2018 | -2.509M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| RadNet, Inc. | 94.10M |
| Lumexa Imaging Holdings, Inc. | 32.80M |
| Labcorp Holdings, Inc. | 445.50M |
| Quest Diagnostics, Inc. | 597.00M |
| OPKO Health, Inc. | -43.50M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -15.96M |
| Cash from Financing (Quarterly) | -0.886M |
| Free Cash Flow | -0.489M |
| Free Cash Flow Per Share (Quarterly) | 0.2155 |
| Free Cash Flow to Equity (Quarterly) | 6.625M |
| Free Cash Flow to Firm (Quarterly) | 6.786M |
| Free Cash Flow Yield | -0.05% |